DACT2 and breast carcinoma: Reduction of miR-503-3p repressed glycolysis and promoted mitochondrial oxidative phosphorylation in breast cancer cells and decreased tumor growth by overexpressing DACT2 and inactivating the Wnt/β-catenin signaling pathway 69.